| Adaption and Testing of the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire for Parents With Children From 0-4 (NCT05603936) | Universitätsklinikum Hamburg-Eppendorf | 2022-03-01 |
| A Trial of YPEG-rhGH in Children With Short Stature (NCT05838885) | Xiamen Amoytop Biotech Co., Ltd. | 2022-02-15 |
| Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature (NCT04798690) | Dong-A ST Co., Ltd. | 2021-02-08 |
| Ultrasound Evaluation of Fetal Hemodynamics and Perinatal Complications (NCT03865628) | Centre Hospitalier Universitaire de Besancon | 2019-03-01 |
| Effects of Serial Plotting on Fundal Height Charts on Identification and Outcomes of Small for Gestational Age Infants (NCT02964793) | University Hospital, Grenoble | 2018-01-01 |
| Cardiovascular Screening in Infants Born Small for Gestational Age (NCT03758092) | Azienda Ospedaliero Universitaria Maggiore della Carita | 2017-09-01 |
| Investigating the Structured Use of Ultrasound Scanning for Fetal Growth (NCT03662178) | Oxford University Hospitals NHS Trust | 2017-09-01 |
| Effect of Insulin Sensitization on IGF-1 Response to Growth Hormone in SGA Children (NCT02931591) | Cambridge University Hospitals NHS Foundation Trust | 2016-11-01 |
| Assessing the Feasibility of Integrating Maternal Nutrition Interventions Into an Existing MNCH Platform in Bangladesh (NCT02745249) | International Food Policy Research Institute | 2015-07-01 |
| Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. (NCT02280031) | CHU de Quebec-Universite Laval | 2014-11-01 |
| ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes (NCT02218931) | Queen Mary University of London | 2014-09-12 |
| Growth and Asymmetric diMethylArginine (NCT03422081) | University Hospital, Lille | 2014-06-01 |
| Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children (NCT01604395) | LG Chem | 2012-01-01 |
| Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone (NCT01327924) | Novo Nordisk A/S | 2011-04-01 |
| Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents (NCT01245374) | Novo Nordisk A/S | 2010-11-01 |
| Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing (NCT01110928) | Novo Nordisk A/S | 2009-11-26 |
| Epigenetic Markers of B-Cell Function in Low Birth Weight Infants (NCT00925925) | University of Utah | 2009-06-01 |
| Long Term Use of Somatropin in Patients Small for Gestational Age (NCT00793325) | Pfizer | 2009-02-01 |
| Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects (NCT00787878) | Novo Nordisk A/S | 2009-02-01 |
| Safety and Efficacy of Omnitrope® (rhGH) in Short Children Born Small for Gestational Age (SGA) (NCT00537914) | Sandoz | 2008-02-06 |
| Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH) (NCT00597480) | Assistance Publique - Hôpitaux de Paris | 2008-01-01 |
| Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector (NCT00738205) | Merck KGaA, Darmstadt, Germany | 2007-06-01 |
| French National Registry of Children Born Small for Gestational Age Treated With Somatropin (NCT01578135) | Novo Nordisk A/S | 2007-03-18 |
| Maternal Obesity and Small for Gestational Age Infants (NCT00371657) | Oklahoma State University Center for Health Sciences | 2006-07-01 |
| Observational Prospective Study on Patients Treated With Norditropin® (NCT00960128) | Novo Nordisk A/S | 2006-04-01 |
| Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction (NCT00519844) | Novo Nordisk A/S | 2005-07-01 |
| Constructing an Insulin-Like Growth Factor-based Prediction Model (NCT00263445) | University of California, Los Angeles | 2004-08-01 |
| Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age (NCT00557336) | Novo Nordisk A/S | 2003-07-28 |
| Efficacy on Height in SGA Children Treated With Growth Hormone (NCT00184756) | Novo Nordisk A/S | 2002-11-01 |
| Safety and Efficacy of Long-term Somatropin Treatment in Children (NCT01543867) | Novo Nordisk A/S | 2001-01-01 |
| Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation (NCT01734447) | Novo Nordisk A/S | 2000-04-30 |
| Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years (NCT00184691) | Novo Nordisk A/S | 1999-04-01 |
| Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation (NCT01697644) | Novo Nordisk A/S | 1990-10-01 |